Toxic adjuvants alter the function and phenotype of dendritic cells to initiate adaptive immune responses induced by oralHelicobacter pylorivaccines

Helicobacter ◽  
2018 ◽  
Vol 23 (6) ◽  
Author(s):  
Shuanghui Luo ◽  
Wei Liu ◽  
Zhiqin Zeng ◽  
Feng Ye ◽  
Chupeng Hu ◽  
...  
2017 ◽  
Vol 27 (1) ◽  
pp. 71-79 ◽  
Author(s):  
Rituparna Chakraborty ◽  
Janin Chandra ◽  
Shuai Cui ◽  
Lynn Tolley ◽  
Matthew A. Cooper ◽  
...  

Viruses ◽  
2009 ◽  
Vol 1 (3) ◽  
pp. 1022-1034 ◽  
Author(s):  
Artur Summerfield ◽  
Kenneth McCullough

2019 ◽  
Vol 7 (10) ◽  
pp. 402
Author(s):  
Titus Abiola Olukitibi ◽  
Zhujun Ao ◽  
Mona Mahmoudi ◽  
Gary A. Kobinger ◽  
Xiaojian Yao

In the prevention of epidemic and pandemic viral infection, the use of the antiviral vaccine has been the most successful biotechnological and biomedical approach. In recent times, vaccine development studies have focused on recruiting and targeting immunogens to dendritic cells (DCs) and macrophages to induce innate and adaptive immune responses. Interestingly, Ebola virus (EBOV) glycoprotein (GP) has a strong binding affinity with DCs and macrophages. Shreds of evidence have also shown that the interaction between EBOV GP with DCs and macrophages leads to massive recruitment of DCs and macrophages capable of regulating innate and adaptive immune responses. Therefore, studies for the development of vaccine can utilize the affinity between EBOV GP and DCs/macrophages as a novel immunological approach to induce both innate and acquired immune responses. In this review, we will discuss the unique features of EBOV GP to target the DC, and its potential to elicit strong immune responses while targeting DCs/macrophages. This review hopes to suggest and stimulate thoughts of developing a stronger and effective DC-targeting vaccine for diverse virus infection using EBOV GP.


Genes ◽  
2020 ◽  
Vol 11 (3) ◽  
pp. 323 ◽  
Author(s):  
Guoying Wang ◽  
Xianghui Li ◽  
Lei Zhang ◽  
Abualgasim Elgaili Abdalla ◽  
Tieshan Teng ◽  
...  

Dendritic cells (DCs) play a critical role in the immune system which sense pathogens and present their antigens to prime the adaptive immune responses. As the progression of sepsis occurs, DCs are capable of orchestrating the aberrant innate immune response by sustaining the Th1/Th2 responses that are essential for host survival. Hence, an in-depth understanding of the characteristics of DCs would have a beneficial effect in overcoming the obstacle occurring in sepsis. This paper focuses on the role of DCs in the progression of sepsis and we also discuss the reverse sepsis-induced immunosuppression through manipulating the DC function. In addition, we highlight some potent immunotherapies that could be used as a novel strategy in the early treatment of sepsis.


2008 ◽  
Vol 86 (7) ◽  
pp. 580-587 ◽  
Author(s):  
Sandra J Vliet ◽  
Juan J García‐Vallejo ◽  
Yvette Kooyk

2001 ◽  
Vol 166 (7) ◽  
pp. 4446-4455 ◽  
Author(s):  
Taro Fukao ◽  
David M. Frucht ◽  
George Yap ◽  
Massimo Gadina ◽  
John J. O’Shea ◽  
...  

2021 ◽  
Vol 12 ◽  
Author(s):  
Indumathi Manoharan ◽  
Puttur D. Prasad ◽  
Muthusamy Thangaraju ◽  
Santhakumar Manicassamy

For decades, lactate has been considered an innocuous bystander metabolite of cellular metabolism. However, emerging studies show that lactate acts as a complex immunomodulatory molecule that controls innate and adaptive immune cells’ effector functions. Thus, recent advances point to lactate as an essential and novel signaling molecule that shapes innate and adaptive immune responses in the intestine and systemic sites. Here, we review these recent advances in the context of the pleiotropic effects of lactate in regulating diverse functions of immune cells in the tissue microenvironment and under pathological conditions.


Blood ◽  
2011 ◽  
Vol 118 (21) ◽  
pp. 1113-1113
Author(s):  
Brian T. Edelson ◽  
Kenneth M. Murphy

Abstract Abstract 1113 Granulocyte/macrophage colony stimulating factor (GM-CSF) regulates the development and activity of several myeloid cell types, including dendritic cells (DCs), thereby influencing the initiation and maintenance of adaptive immune responses. Mice lacking GM-CSF or its receptor show decreased antigen specific T cell priming against the encephalitogenic peptide of myelin oligodendrocyte glycoprotein (MOG35–55), and are resistant to experimental autoimmune encephalitis (EAE), a mouse model of multiple sclerosis. Beyond this role in priming adaptive immune responses, GM-CSF acts to sustain ongoing T cell effector responses, both in EAE initiated by MOG35–55 peptide and in other models of autoimmunity. A recent report has argued that part of the role for GM-CSF in EAE is based on its requirement for the development of a subset of dermal DCs, termed CD11blow/−Langerin+CD103+ DCs (J Exp Med. 207:953–61, 2010). These dermal DCs represent one anatomic subtype of peripheral tissue CD11blow/−CD103+ DCs, and share the properties of efficient antigen cross-presentation and IL-12 production with lymphoid tissue-resident CD8α+ DCs. Peripheral tissue CD11blow/−CD103+ DCs and lymphoid tissue-resident CD8α+ DCs are developmentally related, each being dependent on FMS-like tyrosine kinase 3 ligand (Flt3L), and requiring the transcription factors Batf3, Irf8, and Id2 for development. Mice deficient in any one of these transcription factors selectively lack these DC subsets, with Batf3−/− mice representing the best model for studying the role of these DCs in vivo, as Irf8−/− and Id2−/− mice display more widespread immune defects. Here, we directly compared the development of peripheral tissue DCs and susceptibility to EAE in GM-CSF receptor deficient (Csf2rb−/−) and Batf3−/− mice. We confirmed that Csf2rb−/− mice displayed poor priming of MOG35-55 peptide-specific T cell responses and resisted induction of EAE. Importantly, however, we found that Batf3-dependent dermal CD11blow/−Langerin+ DCs did, in fact, develop in Csf2rb−/− mice, but that these DCs expressed reduced, but not absent, levels of the surface marker CD103. In contrast, Batf3−/− mice, lacking all peripheral CD11blow/− DCs and lymphoid tissue-resident CD8α+ DCs, showed robust Th cell priming after subcutaneous immunization, and were fully susceptible to EAE. These results exclude the hypothesis that defective T effector cell priming and resistance to EAE exhibited by Csf2rb−/− mice result from the absence of dermal CD11blow/−Langerin+CD103+ DCs, and instead suggest that GM-CSF is acting via different mechanisms to promote autoimmunity. Disclosures: No relevant conflicts of interest to declare.


Sign in / Sign up

Export Citation Format

Share Document